跨膜蛋白
细胞生物学
诱导剂
信号转导
NF-κB
肿瘤坏死因子α
受体
跨膜结构域
化学
配体(生物化学)
生物
生物化学
免疫学
基因
作者
Claudia Roos,Andreas Wicovsky,Nicole Müller,Steffen Salzmann,Tina Rosenthal,Holger Kalthoff,Anna Trauzold,Axel Seher,Frank Henkler,Christian Kneitz,Harald Wajant
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2010-07-08
卷期号:185 (3): 1593-1605
被引量:93
标识
DOI:10.4049/jimmunol.0903555
摘要
TNF-like weak inducer of apoptosis, TWEAK, is a typical member of the TNF ligand family. Thus, it is initially expressed as a type II transmembrane protein from which a soluble variant can be released by proteolytic processing. In this study, we show that membrane TWEAK is superior to soluble variant of TWEAK (sTWEAK) with respect to the activation of the classical NF-kappaB pathway, whereas both TWEAK variants are potent inducers of TNFR-associated factor-2 depletion, NF-kappaB-inducing kinase accumulation and p100 processing, hallmarks of activation of the noncanonical NF-kappaB pathway. Like other soluble TNF ligands with a poor capability to activate their corresponding receptor, sTWEAK acquires an activity resembling those of the transmembrane ligand by oligomerization or cell surface-immobilization. Blockade of the Fn14 receptor inhibited NF-kappaB signaling irrespective of the TWEAK form used for stimulation, indicating that the differential activities of the two TWEAK variants on classical and noncanonical NF-kappaB signaling is not related to the use of different receptors.
科研通智能强力驱动
Strongly Powered by AbleSci AI